Mira Pharmaceuticals Files 2024 10-K Amendment

Ticker: MIRA · Form: 10-K/A · Filed: Apr 17, 2025 · CIK: 1904286

Mira Pharmaceuticals, Inc. 10-K/A Filing Summary
FieldDetail
CompanyMira Pharmaceuticals, Inc. (MIRA)
Form Type10-K/A
Filed DateApr 17, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: amendment, annual-report, pharmaceuticals

TL;DR

Mira Pharma filed its 2024 10-K amendment, check for updates.

AI Summary

Mira Pharmaceuticals, Inc. filed an amendment (No. 2) to its 2024 annual report on April 17, 2025. The company, formerly known as Mira1a Therapeutics, Inc., is incorporated in Florida and headquartered in Miami. This filing pertains to the fiscal year ended December 31, 2024.

Why It Matters

This amendment provides updated financial and operational information for Mira Pharmaceuticals for the fiscal year 2024, which is crucial for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — This filing is an amendment to a previously submitted annual report and does not appear to introduce new material risks.

Key Numbers

  • 001-41765 — SEC File Number (Identifies the company's filings with the SEC.)
  • 853354547 — EIN (Employer Identification Number for tax purposes.)

Key Players & Entities

  • MIRA Pharmaceuticals, Inc. (company) — Registrant
  • Mira1a Therapeutics, Inc. (company) — Former company name
  • 2024 (date) — Fiscal year end
  • April 17, 2025 (date) — Filing date
  • Florida (location) — State of incorporation and business address
  • Miami (location) — Business address city

FAQ

What is the purpose of this 10-K/A filing?

This is Amendment No. 2 to the annual report for the fiscal year ended December 31, 2024, filed by Mira Pharmaceuticals, Inc.

When was this amendment filed?

The amendment was filed on April 17, 2025.

What was Mira Pharmaceuticals, Inc. formerly known as?

The company was formerly known as Mira1a Therapeutics, Inc.

Where is Mira Pharmaceuticals, Inc. headquartered?

The company's principal executive offices are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.

What is the SEC file number for Mira Pharmaceuticals, Inc.?

The SEC file number for Mira Pharmaceuticals, Inc. is 001-41765.

Filing Details

This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 17, 2025 regarding MIRA PHARMACEUTICALS, INC. (MIRA).

View full filing on EDGAR

View Full Filing

View this 10-K/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.